Jefferies Remains Bullish Following Amphastar Pharma's (AMPH) Strong Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Amphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015
May 13, 2015 6:00 AM EDTRANCHO CUCAMONGA, Calif., May 13, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH) ("Amphastar" or the "Company") today reported results for the first quarter ended March 31, 2015.
Net revenues of $56.9 million for the first quarter GAAP net loss of $0.7 million, or $0.01 per diluted share for the first quarter Adjusted non-GAAP net loss of $0.4 million, or $0.01 per diluted share for the first quarter  Three Months Ended March 31,  2015 2014  (in thousands, except per share data) Net... More